why choose us

First received: October 23, 2023

Clinical Trial: Physiologic Markers of Cardiometabolic Risk in People With Type 1 Diabetes

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: type1diabetes

Study Type: INTERVENTIONAL


Official Title: Physiologic Markers of Cardiometabolic Risk in People With Type 1 Diabetes

Brief Summary: More than 40% of young adults with type 1 diabetes (T1D) also have overweight or obesity.Each of these diagnoses increase the risk of adverse cardiovascular events.Investigators aim to obtain reference data for individuals with T1D who do not have overweight obesity, to understand how close GLP-1 analogue obesity treatment in those with overweight/obesity brings physiologic markers of cardiometabolic risk to those with BMI in the normal range.Specifically, investigators will describe how drivers of…

Read more